Leidos seeks industry participation for JP2060 Phase 4 bid
Leidos Australia is calling on Australian industry participation in its bid for the Joint Project 2060 (JP2060) Phase 4 Health Knowledge Management (HKM) Solution.
The multi-phase JP2060 project is being led by the Capability Acquisition and Sustainment Group (CASG) within the Australian Department of Defence.
JP2060 Phase 4 seeks to acquire and sustain a commercial, information technology (IT), enterprise knowledge solution that captures health data, and collates and manages the information across the Australian Defence Force health care continuum within the deployed and non-deployed, garrison environment.
The solution will be required to provide greater healthcare business functionality, utilise an efficient health informatics process and enable efficient and safe, evidenced based, patient-centric care. The HKM solution will be required to interface with Defence ICT platforms, allied coalition partners, Australian healthcare providers and nominated Government agencies.
The HKM solution will be a predominately commercial-off-the shelf solution that meets Australian Clinical Practice Guidelines and is operating in the Australian market. The primary capabilities that Leidos Australia are seeking support from Australian industry in relation to the JP2060 Phase 4 HKM Project include:
- dental software and applications
- pharmaceutical software and applications
- health analytics
- decision support
- hazard and threat modelling
- veterinarian software and applications
Leidos Australia is looking to connect with industry participants who may be able to provide some or all of these capabilities. Register your interest.
Those companies who registered interest with Leidos Australia under the previous JP2060 Phase 3 Deployable Healthcare Capability Project do not need to re-register.
You can view the original JP2060 Phase 4 Request for Information, published 26 February 2018.